Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603)

BACKGROUND: Hot flashes (HFs) negatively affect quality of life among perimenopausal and postmenopausal women. This study investigated the efficacy of oxybutynin vs placebo in decreasing HFs. METHODS: In this randomized, multicenter, double-blind study, women with and without breast cancer with 28 o...

Descripción completa

Detalles Bibliográficos
Autores principales: Leon-Ferre, Roberto A, Novotny, Paul J, Wolfe, Eric G, Faubion, Stephanie S, Ruddy, Kathryn J, Flora, Daniel, Dakhil, Christopher S R, Rowland, Kendrith M, Graham, Mark L, Le-Lindqwister, Nguyet, Smith, Thomas J, Loprinzi, Charles L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7050158/
https://www.ncbi.nlm.nih.gov/pubmed/32337497
http://dx.doi.org/10.1093/jncics/pkz088

Ejemplares similares

Ejemplares similares